Windtree Therapeutics (WINT) Institutional Ownership $0.83 0.00 (-0.24%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$0.81 -0.02 (-2.17%) As of 05/16/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Windtree Therapeutics (NASDAQ:WINT)CurrentInstitutional OwnershipPercentage29.33%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.08MNumber ofInstitutional Sellers(last 12 months)0 Get WINT Insider Trade Alerts Want to know when executives and insiders are buying or selling Windtree Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data WINT Institutional Buying and Selling by Quarter Windtree Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC119,266$42K0.0%N/A1.079% 8/7/2023Acadian Asset Management LLC31,583$39K0.0%N/A0.613% 7/27/2023 Virtu Financial LLC42,667$54K0.0%N/A0.828% 11/7/2022 Virtu Financial LLC100,808$30K0.0%+559.5%0.329% 10/13/2022PVG Asset Management Corp187,060$56K0.2%N/A0.611% 11/12/2021 Renaissance Technologies LLC187,400$386K0.0%+28.6%0.702% 11/10/2021 Skandinaviska Enskilda Banken AB publ110,500$228K0.0%+15.7%0.414% 11/9/2021BlackRock Inc.49,708$102K0.0%-13.6%0.186% 8/16/2021 State Street Corp19,300$44K0.0%N/A0.072% 8/16/2021Frontier Wealth Management LLC60,000$137K0.0%N/A0.225% 8/16/2021 Goldman Sachs Group Inc.66,952$153K0.0%N/A0.251% 8/13/2021 Renaissance Technologies LLC145,700$334K0.0%+1,156.0%0.546% 8/13/2021 Northern Trust Corp65,380$149K0.0%+28.8%0.245% 8/13/2021 Geode Capital Management LLC69,082$158K0.0%N/A0.259% 8/13/2021 Vanguard Group Inc.626,057$1.43M0.0%+16.1%2.344% 8/10/2021 Skandinaviska Enskilda Banken AB publ95,500$219K0.0%N/A0.364% 5/21/2021 Citadel Advisors LLC66,035$162K0.0%N/A0.251% 5/18/2021 Citadel Advisors LLC66,035$162K0.0%N/A0.251% 5/17/2021 HRT Financial LP23,365$57K0.0%N/A0.089% 5/14/2021PVG Asset Management Corp63,795$156K0.5%N/A0.243% 5/13/2021 Renaissance Technologies LLC11,600$28K0.0%N/A0.044% 5/13/2021 Kepos Capital LP165,000$404K0.0%+83.3%0.628% 5/12/2021 Northern Trust Corp50,743$125K0.0%-29.9%0.193% 5/4/2021 Envestnet Asset Management Inc.36,334$89K0.0%N/A0.138% (Data available from 1/1/2016 forward) WINT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of WINT shares? During the previous two years, the following institutional investors and hedge funds held shares of Windtree Therapeutics shares: Virtu Financial LLC ($54K), and Renaissance Technologies LLC ($42K), Acadian Asset Management LLC ($39K).Learn more on WINT's institutional investors. What percentage of Windtree Therapeutics stock is owned by institutional investors? 29.33% of Windtree Therapeutics stock is owned by institutional investors. Learn more on WINT's institutional investor holdings. Which institutional investors have been buying Windtree Therapeutics stock? The following institutional investors have purchased Windtree Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($119.27K), Virtu Financial LLC ($42.67K), and Acadian Asset Management LLC ($31.58K). How much institutional buying is happening at Windtree Therapeutics? Institutional investors have bought a total of 193,516 shares in the last 24 months. This purchase volume represents approximately $85.61M in transactions. Related Companies TRIB Institutional Ownership NRSN Institutional Ownership MBRX Institutional Ownership BCTX Institutional Ownership EQ Institutional Ownership GOVX Institutional Ownership MRKR Institutional Ownership SYBX Institutional Ownership CLDI Institutional Ownership MEIP Institutional Ownership This page (NASDAQ:WINT) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.